Showing results (31-40 of 95) with videos related to

Sort By:
Pageof 10
Journal of Behavioral Medicine|March 5, 2025
Worry about prostate cancer and risk perception among middle-aged men: results from the PROBASE trialValentin H Meissner, Andreas Dinkel, Martina Kron, et al.
International Journal of Radiation Oncology, Biology, Physics|June 15, 2015
XRCC1 Polymorphism Associated With Late Toxicity After Radiation Therapy in Breast Cancer PatientsPetra Seibold, Sabine Behrens, Peter Schmezer, et al.
Breast Cancer Research and Treatment|February 21, 2013
A genome-wide association study to identify genetic susceptibility loci that modify ductal and lobular postmenopausal breast cancer risk associated with menopausal hormone therapy use: a two-stage design with replicationRebecca Hein, Dieter Flesch-Janys, Norbert Dahmen, et al.
BMC Cancer|December 18, 2015
A polymorphism in the base excision repair gene PARP2 is associated with differential prognosis by chemotherapy among postmenopausal breast cancer patientsPetra Seibold, Peter Schmezer, Sabine Behrens, et al.
Breast Cancer Research : BCR|August 16, 2015
A comprehensive evaluation of interaction between genetic variants and use of menopausal hormone therapy on mammographic densityAnja Rudolph, Peter A Fasching, Sabine Behrens, et al.
International Journal of Cancer|July 4, 2017
Gene-environment interactions involving functional variants: Results from the Breast Cancer Association ConsortiumMyrto Barrdahl, Anja Rudolph, John L Hopper, et al.
Endocrine-Related Cancer|October 2, 2013
Genetic modifiers of menopausal hormone replacement therapy and breast cancer risk: a genome-wide interaction studyAnja Rudolph, Rebecca Hein, Sara Lindström, et al.
Genome Medicine|May 8, 2026
The contribution of rare germline variants to the immune landscape of breast cancerFelipe Rojas-Rodríguez, Sander Canisius, Renske Keeman, et al.
Oncotarget|February 10, 2017
TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancerRainer Fagerholm, Sofia Khan, Marjanka K Schmidt, et al.
Nature Genetics|August 17, 2023
Exome sequencing identifies breast cancer susceptibility genes and defines the contribution of coding variants to breast cancer riskNaomi Wilcox, Martine Dumont, Anna González-Neira, et al.
Pageof 10